TodayBuildContextBrowseMore
stackBETAv0.1
TodayCabinetBuild a stackCommon stacksEncyclopediaPulse
Methodology
← Back to your stack
Monograph
FDA APPROVEDN-013
Cognition

Caffeine

Adenosine receptor antagonist. The world's most-consumed psychoactive compound. Blocks A1 + A2A adenosine receptors, preventing sleep-pressure accumulation and releasing dopamine/norepinephrine. Cognitive enhancement is the most robustly documented effect in all of pharmacology.

EstablishedCognition
Typical dose100–200 mg (supplement form); 80–100 mg per cup of coffee
Frequencymorning + early afternoon; avoid after 2pm for sleep quality
Half-life5h
Citations indexed300
DeliveryOral
Half-life~5h
EvidenceEstablished
Citations300
Similar compounds
Synergy checkCompare
Mechanism

1,3,7-trimethylxanthine. Half-life varies 3–7 hours by CYP1A2 genotype — the single most clinically meaningful pharmacogenomic effect in this catalog. Fast metabolizers (CYP1A2 *1F homozygous) clear caffeine in ~3 hr and may benefit from more frequent, smaller doses; slow metabolizers (CYP1A2 *1A) retain caffeine 5–7+ hr and are at higher cardiovascular risk with regular high intake. The L-theanine 2:1 stack (200 mg theanine + 100 mg caffeine) is the single most consistent nootropic combination in the literature — theanine attenuates jitter without reducing alertness. Tolerance builds within 1–2 weeks of daily use; washout takes ~1 week.

Specifics
Focus / attentionLow energy / fatigueBrain fog
Caveats

PURE POWDERED CAFFEINE WARNING: FDA has taken action against highly concentrated powders — 1 teaspoon (~3.2 g) is roughly 28 cups of coffee and has caused deaths. If using powder, pre-weigh doses with a milligram scale, never eyeball. CYP1A2 slow metabolizers face higher cardiovascular risk with regular 400+ mg/day intake (elevated blood pressure, arrhythmia risk in susceptible individuals). Tolerance builds fast; cycling preserves effect. Withdrawal headache on cessation is real and lasts 1–3 days.

Evidence levelEstablished
Regulatory statusGRAS in US. FDA action level for pure powdered caffeine: doses equivalent to 10+ cups of coffee (risk of accidental lethal dosing). Supplement form at standard doses is freely legal everywhere.
DNA / pharmacogenomicsModerate — CYP1A2 genotype determines half-life (3–7 hr range). ADORA2A rs5751876 variant affects sensitivity to caffeine-induced anxiety — anxious caffeine responders are often homozygous for the T allele. These are the two most actionable caffeine pharmacogenomic variants and are included in most DTC panels.
References

External links to PubMed searches, ClinicalTrials.gov, and FDA materials. We do not host papers — we point at canonical sources.

  • PubMedEN
    REVIEWIndustry-fundedVerified today
    Einöther SJ + Giesbrecht T — Caffeine cognitive effects review (Psychopharmacology 2013)
  • RegulatoryEN
    REGULATORYNIH-fundedVerified today
    FDA — Highly concentrated caffeine in dietary supplements (safety communication)
FDA APPROVEDN-013

GRAS in US. FDA action level for pure powdered caffeine: doses equivalent to 10+ cups of coffee (risk of accidental lethal dosing). Supplement form at standard doses is freely legal everywhere.

Can I get it? →
Field reports

Distilled themes from named communities — Reddit threads, forums, creator commentary. Not direct quotes; not clinical evidence. Useful for calibrating expectations against what real self-experimenters report.

r/Nootropics + virtually every productivity community

Caffeine is the entry-point compound for every nootropic discussion. Cohort consensus: L-theanine 2:1 stack is non-negotiable for daily users — jitter disappears, alertness stays. CYP1A2 genotyping is one of the most practically useful DTC genetic tests because dosing timing directly follows from it. Tolerance cycling (5 days on / 2 days off) is the community gold standard.

Caffeine100–200 mg (supplement form); 80–100 mg per cup of coffee · morning + early afternoon; avoid after 2pm for sleep quality
Discussion guide, not prescription

stack is an exploration engine. Output is a discussion guide for a conversation with a licensed provider — never a prescription, dose recommendation, or sourcing instruction. Peptides discussed include compounds with limited human evidence and varying legal status by jurisdiction. Verify everything with a qualified clinician before any decision.

Full terms →
stackv0.1
AudiencesWho Stack is forFor researchersFor pharmaciesFor cliniciansFor press
Trust & regulatoryCalibrationMethodologyFDA statusPharmacy registryPCAC commentMX · COFEPRIS
Built honest. Bilingual from day one.